Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560861508> ?p ?o ?g. }
- W2560861508 endingPage "10170" @default.
- W2560861508 startingPage "10161" @default.
- W2560861508 abstract "// Jun Feng 1 , Hua-Wen Chen 1 , Li-Juan Pi 1 , Jin Wang 1 , Da-Qian Zhan 1 1 Department of Emergency Medicine, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, Hubei, P.R. China Correspondence to: Hua-Wen Chen, email: ellewzh443@163.com Keywords: tanshinone IIA, cardiac hypertrophy, Cys-C/Wnt signaling pathway, spontaneously hypertensive rats Received: July 30, 2016 Accepted: November 09, 2016 Published: December 28, 2016 ABSTRACT The study aimed to investigate the protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats (SHRs) through the Cys-C/Wnt signaling pathway. Thirty SHRs were randomly divided into cardiac hypertrophy, low- and high-dose tanshinone IIA groups. Ten Wistar-Kyoto rats were selected as control group. The systolic blood pressure (SBP), heart weight (HW), left ventricular weight (LVW) and body weight (BW) of all rats were recorded. HE staining and qRT-PCR were applied to observe the morphology of myocardial tissue and mRNA expressions of COL1A1 and COL3A1. ELISA and Western blotting were used to measure the serum asymmetric dimethylarginine (ADMA), nitric oxide (NO) and cardiac troponin I (cTnI) levels, and the expressions of the Cys-C/Wnt signaling pathway-related proteins, eNOS and Nox4. Compared with the cardiac hypertrophy group, the SBP, HW/BW, LVW/BW, swelling degree of myocardial cells, COL1A1 and COL3A1 mRNA expressions, serum cTnI and ADMA levels, and the Cys-C/Wnt signaling pathway-related proteins and Nox4 expressions in the low- and high-dose tanshinone IIA groups were decreased, but the endothelial NO synthase (eNOS), phosphorylated eNOS (Ser1177) and NO expressions were increased. No significant difference was found between the low- and high-dose tanshinone IIA groups. Our study indicated a protective effect of tanshinone IIA against cardiac hypertrophy in SHRs through inhibiting the Cys-C/Wnt signaling pathway." @default.
- W2560861508 created "2017-01-06" @default.
- W2560861508 creator A5018244700 @default.
- W2560861508 creator A5032334892 @default.
- W2560861508 creator A5033254913 @default.
- W2560861508 creator A5083654638 @default.
- W2560861508 creator A5085059167 @default.
- W2560861508 date "2016-12-28" @default.
- W2560861508 modified "2023-09-26" @default.
- W2560861508 title "Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway" @default.
- W2560861508 cites W1489434331 @default.
- W2560861508 cites W1799049754 @default.
- W2560861508 cites W1966971242 @default.
- W2560861508 cites W1973677547 @default.
- W2560861508 cites W1983391648 @default.
- W2560861508 cites W1997393902 @default.
- W2560861508 cites W1997768760 @default.
- W2560861508 cites W1998719302 @default.
- W2560861508 cites W2000656182 @default.
- W2560861508 cites W2002431814 @default.
- W2560861508 cites W2012694124 @default.
- W2560861508 cites W2018475598 @default.
- W2560861508 cites W2022028734 @default.
- W2560861508 cites W2029667845 @default.
- W2560861508 cites W2038229511 @default.
- W2560861508 cites W2039470592 @default.
- W2560861508 cites W2045142779 @default.
- W2560861508 cites W2045288233 @default.
- W2560861508 cites W2048156663 @default.
- W2560861508 cites W2065890888 @default.
- W2560861508 cites W2069474296 @default.
- W2560861508 cites W2076168707 @default.
- W2560861508 cites W2081882557 @default.
- W2560861508 cites W2100596020 @default.
- W2560861508 cites W2104608518 @default.
- W2560861508 cites W2107990955 @default.
- W2560861508 cites W2112267856 @default.
- W2560861508 cites W2115941607 @default.
- W2560861508 cites W2123784972 @default.
- W2560861508 cites W2133535805 @default.
- W2560861508 cites W2136466466 @default.
- W2560861508 cites W2146014720 @default.
- W2560861508 cites W2147069120 @default.
- W2560861508 cites W2155016605 @default.
- W2560861508 cites W2182587120 @default.
- W2560861508 cites W2202680715 @default.
- W2560861508 cites W2479131075 @default.
- W2560861508 cites W786062 @default.
- W2560861508 doi "https://doi.org/10.18632/oncotarget.14328" @default.
- W2560861508 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5354649" @default.
- W2560861508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28053285" @default.
- W2560861508 hasPublicationYear "2016" @default.
- W2560861508 type Work @default.
- W2560861508 sameAs 2560861508 @default.
- W2560861508 citedByCount "18" @default.
- W2560861508 countsByYear W25608615082017 @default.
- W2560861508 countsByYear W25608615082018 @default.
- W2560861508 countsByYear W25608615082019 @default.
- W2560861508 countsByYear W25608615082020 @default.
- W2560861508 countsByYear W25608615082021 @default.
- W2560861508 countsByYear W25608615082022 @default.
- W2560861508 crossrefType "journal-article" @default.
- W2560861508 hasAuthorship W2560861508A5018244700 @default.
- W2560861508 hasAuthorship W2560861508A5032334892 @default.
- W2560861508 hasAuthorship W2560861508A5033254913 @default.
- W2560861508 hasAuthorship W2560861508A5083654638 @default.
- W2560861508 hasAuthorship W2560861508A5085059167 @default.
- W2560861508 hasBestOaLocation W25608615081 @default.
- W2560861508 hasConcept C115725540 @default.
- W2560861508 hasConcept C126322002 @default.
- W2560861508 hasConcept C134018914 @default.
- W2560861508 hasConcept C137620995 @default.
- W2560861508 hasConcept C167414201 @default.
- W2560861508 hasConcept C185592680 @default.
- W2560861508 hasConcept C2777622882 @default.
- W2560861508 hasConcept C2778326061 @default.
- W2560861508 hasConcept C500558357 @default.
- W2560861508 hasConcept C519581460 @default.
- W2560861508 hasConcept C55493867 @default.
- W2560861508 hasConcept C62478195 @default.
- W2560861508 hasConcept C71924100 @default.
- W2560861508 hasConcept C84393581 @default.
- W2560861508 hasConcept C98274493 @default.
- W2560861508 hasConceptScore W2560861508C115725540 @default.
- W2560861508 hasConceptScore W2560861508C126322002 @default.
- W2560861508 hasConceptScore W2560861508C134018914 @default.
- W2560861508 hasConceptScore W2560861508C137620995 @default.
- W2560861508 hasConceptScore W2560861508C167414201 @default.
- W2560861508 hasConceptScore W2560861508C185592680 @default.
- W2560861508 hasConceptScore W2560861508C2777622882 @default.
- W2560861508 hasConceptScore W2560861508C2778326061 @default.
- W2560861508 hasConceptScore W2560861508C500558357 @default.
- W2560861508 hasConceptScore W2560861508C519581460 @default.
- W2560861508 hasConceptScore W2560861508C55493867 @default.
- W2560861508 hasConceptScore W2560861508C62478195 @default.
- W2560861508 hasConceptScore W2560861508C71924100 @default.
- W2560861508 hasConceptScore W2560861508C84393581 @default.
- W2560861508 hasConceptScore W2560861508C98274493 @default.